Page 6 - யேல் பல்கலைக்கழகம் பள்ளி ஆஃப் பொது ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Print Beliefs about and experiences with healthcare may influence people’s use of the HIV prevention pill, says Rutgers study Cisgender sexual minority men and transgender women are aware of pre-exposure prophylaxis (PrEP), a daily pill for HIV-negative people to prevent HIV infection, but few are currently taking it, according to researchers at Rutgers. The study, published in the journal AIDS and Behavior, surveyed 202 young sexual minority men and transgender women – two high-priority populations for HIV prevention – to better understand why some were more likely than others to be taking PrEP. The researchers, who are part of the Rutgers School of Public Health’s Center for Health, Identity, Behavior and Prevention Studies (CHIBPS), found that while 98 percent of the study’s participants were aware of PrEP, less than 25 percent were currently taking it.

Perryn halkitisCaleb loschiavoCenters for diseaseYale university school of public healthUniversity of alabamaRutgers school of public healthRutgers school of public health centerDisease controlRutgers schoolPublic healthPrevention studiesYale university schoolமையங்கள் க்கு நோய்யேல் பல்கலைக்கழகம் பள்ளி ஆஃப் பொது ஆரோக்கியம்பல்கலைக்கழகம் ஆஃப் அலபாமாரட்ஜர்ஸ் பள்ளி ஆஃப் பொது ஆரோக்கியம்